Literature DB >> 11802801

L-myc genotype is associated with different susceptibility to lung cancer in smokers.

Hiroshi Kumimoto1, Nobuyuki Hamajima, Yoshio Nishimoto, Keitaro Matsuo, Masayuki Shinoda, Shunzo Hatooka, Kanji Ishizaki.   

Abstract

We have shown that L-myc genotype is associated with the risk of esophageal cancer from smoking and heavy drinking. In this study, we have analyzed the relationship between the L-myc genotypes and lung cancer risk from smoking in 191 Japanese lung-cancer patients and 241 non-cancer controls. The odds ratios (ORs) were markedly higher in SS and LS genotypes than in LL genotype; age-sex-adjusted ORs were 3.19, 2.30 and 0.92, respectively. This result suggests that the L-myc polymorphism may affect the induction of lung cancer by smoking. The OR for smoking in SS-genotype patients diagnosed within 2 years was higher than that in other SS patients, suggesting that smoking-related lung cancer in SS genotype might exhibit a poorer prognosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802801      PMCID: PMC5926866          DOI: 10.1111/j.1349-7006.2002.tb01193.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Adjustment of prognostic effects in prevalent case-control studies on genotype.

Authors:  N Hamajima; K Matsuo; H Yuasa
Journal:  J Epidemiol       Date:  2001-09       Impact factor: 3.211

Review 2.  Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States.

Authors:  G C Kabat
Journal:  Lung Cancer       Date:  1996-08       Impact factor: 5.705

3.  Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors:  I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

Review 4.  Smoking and the molecular epidemiology of lung cancer.

Authors:  D C Christiani
Journal:  Clin Chest Med       Date:  2000-03       Impact factor: 2.878

5.  L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma.

Authors:  J A Taylor; D A Bell; D Nagorney
Journal:  Int J Cancer       Date:  1993-07-30       Impact factor: 7.396

6.  Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.

Authors:  K Kawashima; S Nomura; H Hirai; S Fukushi; T Karube; K Takeuchi; T Naruke; S Nishimura
Journal:  Int J Cancer       Date:  1992-02-20       Impact factor: 7.396

7.  Case-control studies: matched controls or all available controls?

Authors:  N Hamajima; K Hirose; M Inoue; T Takezaki; T Kuroishi; K Tajima
Journal:  J Clin Epidemiol       Date:  1994-09       Impact factor: 6.437

8.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.

Authors:  A Weston; H M Ling-Cawley; N E Caporaso; E D Bowman; R N Hoover; B F Trump; C C Harris
Journal:  Carcinogenesis       Date:  1994-04       Impact factor: 4.944

10.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.